Antipodes Partners’s R1 RCM Inc. Common Stock RCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6,835
Closed -$85.8K 99
2024
Q2
$85.8K Buy
+6,835
New +$85K ﹤0.01% 59
2024
Q1
Sell
-5,623
Closed -$59K 79
2023
Q4
$59K Buy
5,623
+4,561
+429% +$51.7K ﹤0.01% 58
2023
Q3
$16K Buy
+1,062
New +$17.9K ﹤0.01% 68

Other funds holding RCM

Antipodes Partners's RCM Position: Q3 2024 in Review

Antipodes Partners sold out of R1 RCM Inc. Common Stock (RCM) in Q3 2024, closing a stake of 6,835 shares — an estimated $85.8K sold.

Antipodes Partners first reported a position in RCM in Q3 2023 and held it in 3 quarters. The position peaked at $85.8K in Q2 2024. 252 funds tracked by Wall St. Rank hold RCM as of Q3 2024.

  • Antipodes Partners reported no remaining R1 RCM Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Antipodes Partners sold 6,835 R1 RCM Inc. Common Stock shares in Q3 2024, an estimated $85.8K.
  • Antipodes Partners first reported a position in R1 RCM Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Antipodes Partners's R1 RCM Inc. Common Stock position peaked at $85.8K in Q2 2024.
  • 252 funds tracked by Wall St. Rank held R1 RCM Inc. Common Stock as of Q3 2024.

Based on Antipodes Partners's 13F filing for Q3 2024, filed 14 Nov 2024.